P-Values on Trial: Selective Reporting of (Best Practice Guides Against) Selective Reporting

From The Embassy of Good Science
Cases

P-Values on Trial: Selective Reporting of (Best Practice Guides Against) Selective Reporting

What is this about?

This study presented a legal case from 2009, when the U.S. Supreme Court found guilty of fraud Scott Harkonen, CEO of drug company InterMune. Harkonen reported that a drug Actimmune had statistically significant survival benefits, when in reality it did not.

For whom is this important?

Other information